Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients

The COVID-19 pandemic and its containment strategies have presented unique challenges to India's healthcare infrastructure. While a national lockdown initially resulted in the closure of all licensed liquor shops, it also made healthcare facilities dedicated to the treatment of substance use di...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandit, Prabhat Mani, Bhatia, Gayatri, Sarkar, Siddharth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498440/
https://www.ncbi.nlm.nih.gov/pubmed/33138923
http://dx.doi.org/10.1016/j.jsat.2020.108128
_version_ 1783583510472163328
author Pandit, Prabhat Mani
Bhatia, Gayatri
Sarkar, Siddharth
author_facet Pandit, Prabhat Mani
Bhatia, Gayatri
Sarkar, Siddharth
author_sort Pandit, Prabhat Mani
collection PubMed
description The COVID-19 pandemic and its containment strategies have presented unique challenges to India's healthcare infrastructure. While a national lockdown initially resulted in the closure of all licensed liquor shops, it also made healthcare facilities dedicated to the treatment of substance use disorders challenging to access. Addiction treatment services have been functioning at limited capacity with a lack of consensus on operating procedures. In this article, we present actual case scenarios where lockdown affected substance use and the treatment process, and discuss the policy implications and considerations for both.
format Online
Article
Text
id pubmed-7498440
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74984402020-09-18 Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients Pandit, Prabhat Mani Bhatia, Gayatri Sarkar, Siddharth J Subst Abuse Treat Article The COVID-19 pandemic and its containment strategies have presented unique challenges to India's healthcare infrastructure. While a national lockdown initially resulted in the closure of all licensed liquor shops, it also made healthcare facilities dedicated to the treatment of substance use disorders challenging to access. Addiction treatment services have been functioning at limited capacity with a lack of consensus on operating procedures. In this article, we present actual case scenarios where lockdown affected substance use and the treatment process, and discuss the policy implications and considerations for both. Elsevier Inc. 2020-12 2020-09-18 /pmc/articles/PMC7498440/ /pubmed/33138923 http://dx.doi.org/10.1016/j.jsat.2020.108128 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Pandit, Prabhat Mani
Bhatia, Gayatri
Sarkar, Siddharth
Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients
title Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients
title_full Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients
title_fullStr Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients
title_full_unstemmed Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients
title_short Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients
title_sort treatment experience for opioid use disorder during covid-19 in india: learning from patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498440/
https://www.ncbi.nlm.nih.gov/pubmed/33138923
http://dx.doi.org/10.1016/j.jsat.2020.108128
work_keys_str_mv AT panditprabhatmani treatmentexperienceforopioidusedisorderduringcovid19inindialearningfrompatients
AT bhatiagayatri treatmentexperienceforopioidusedisorderduringcovid19inindialearningfrompatients
AT sarkarsiddharth treatmentexperienceforopioidusedisorderduringcovid19inindialearningfrompatients

Ejemplares similares